| 0003-0524 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0524 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0524 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0524 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0524 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0524 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0524 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0527 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0527 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0527 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0527 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0527 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0527 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0527 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0528 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0528 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0528 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0528 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0528 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0528 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0528 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0852 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0852 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0852 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0852 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0852 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0852 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0852 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0855 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0855 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0855 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0855 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0855 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0855 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0855 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0857 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0857 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0857 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0857 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0857 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0857 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0857 | SPRYCEL | dasatinib | E.R. Squibb & Sons, L.L.C. | NDA | Current |